Stocks
Serina Therapeutics, Inc.SER
AMEXHealthcareBiotechnology$1.76
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing polymer-based drug conjugates for cancer and other diseases. Its lead candidate targets advanced solid tumors, and investors track the stock for its proprietary technology platform and upcoming clinical data readouts.
52W Range: $1.22-$5.29
Congressional Interest in Serina Therapeutics, Inc. (SER)
No congressional trades have been disclosed for Serina Therapeutics, Inc. (SER) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SER?
No congressional trades found for this stock.